by Touch Stone Publishers | Jul 8, 2026
Health systems that deployed clinical AI on the expectation that the FDA would tell them when a tool was safe are now governing a category the agency has stepped back from. On January 6, 2026, the FDA revised its guidance on Clinical Decision Support software, the...
by Touch Stone Publishers | Jul 7, 2026
What Delaware, Brussels, and the Proxy Advisors Now Treat as the Oversight Failure, and the Documents That Close It Before August 2 Approving an AI strategy is not the same as governing it. In 2026 the distance between those two acts stopped being a matter of...
by Touch Stone Publishers | Jul 6, 2026
The Board That Declared AI Oversight Without Building It Did Not Create a Framework. It Created a Liability. The board that directed its CEO to “lead our AI transformation” and then received quarterly strategy briefings on AI adoption did not build an AI...
by Touch Stone Publishers | Jun 30, 2026
The enforcement template is set. The SEC’s Corporate Enforcement and Technology Unit has already demonstrated, with precision, exactly how it will build its next AI washing case. Presto Automation (January 2025, the first public company AI washing settlement,...
by Touch Stone Publishers | Jun 29, 2026
The question every boardroom is asking is the wrong question. Executives across every industry are asking: which AI platform should we choose, which model performs best on our data, which vendor has the strongest track record. These are reasonable operational...